Pregabalin Capsule 150 mg (Pregabalin)

Adult dose

This medication is administered orally, divided into two doses per day regardless of food intake. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose is 150 mg once daily, which may be increased to 300 mg daily after 3 to 7 days, and further increased to a maximum of 600 mg every 7 days thereafter. - Central neuropathic pain: Starting dose is 150 mg once daily, which may be increased to 300 mg daily after 1 week.

Child dose

The safety and efficacy data for children under 12 years of age and adolescents aged 12 to 17 is insufficient, thus administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior, so it is important to closely monitor any mood changes or unusual behavior during treatment. Patients with allergies to any component of this drug should not take it. Patients with diabetes may experience weight gain after taking this medication, which may necessitate adjustments in their blood sugar control medications. If allergic reactions such as angioedema occur, the medication should be stopped immediately and the healthcare provider should be informed. Older adults are at risk of falls or injury due to dizziness or drowsiness, hence caution is particularly advised during the initial phase of treatment. Vision blur or changes in eyesight may occur; if these symptoms develop, consideration should be given to discontinuing the drug. Caution is required when stopping other antiepileptic drugs while taking this medication. Discontinuing this medication suddenly can lead to withdrawal symptoms such as insomnia, headache, and anxiety, so consultation with a healthcare provider is necessary. There is a risk of drug abuse, so patients with a history of substance abuse should definitely consult their healthcare provider before use. Patients with impaired kidney function may require dosage adjustments. Patients with heart disease should use this medication cautiously, and particularly those with congestive heart failure should consult with their healthcare provider. Taking this medication with opioid analgesics can increase central nervous system depressant effects, so caution is needed. Patients with respiratory or neurological diseases, kidney disorders, and older adults may have a risk of severe respiratory depression, so dose adjustment may be necessary. Pregnant women are advised not to take this medication during early pregnancy due to the risk of fetal malformations, and women of childbearing age should use effective contraception. Lactating women should consider stopping breastfeeding or the medication itself, as this drug can be transmitted through breast milk. This medication can cause dizziness and drowsiness; therefore, caution should be exercised when driving or operating machinery after taking it. Severe skin reactions may rarely occur, and if any skin abnormalities appear, the medication should be stopped immediately and the healthcare provider should be informed. Overdose may lead to confusion, drowsiness, and depression, and appropriate treatment should be sought immediately at a medical institution. Keep this medicine out of reach of children and do not transfer it to another container for safety.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attacks, cough with breathing abnormalities and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered state of consciousness, visual disturbances, paralysis, urination

Mild side effects

• Dizziness
• drowsiness
• rhinitis
• increased appetite
• loss of appetite
• hypoglycemia
• confusion
• disorientation
• irritability
• depression

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 15 and 30 degrees Celsius. Proper storage will help preserve the drug's effectiveness for a longer period.

Appearance

Hard capsules with a white upper part and white lower part containing a white or light yellow powder

Package unit

For domestic use - 30 capsules/bottle, For domestic use - 100 capsules/bottle, For export - 30 capsules/box [(10 capsules/PTP × 3)]